Security key
405024100
HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE)
CUSIP: 405024100
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common stock, $0.01 par value per share
- Total 13F shares
- 51,176,074
- Total 13F value
- $4,367,618,453
- Share change
- +598,259
- Put/Call ratio
- 35%
- SEC-reported price per share
- $85.35
- Number of holders
- 296
- Value change
- +$50,781,270
- Number of buys
- 143
- Number of sells
- 156
- Shares outstanding
- 45,420,621
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
296
Top holders
10
HAE full security history
Ownership snapshot
Full 13F holder table
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
Broader feeds
Ownership snapshot
Top reported holders of HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Comparable ownership
Top 5
Capital Research Global Investors
14%
BlackRock Finance, Inc.
13%
VANGUARD GROUP INC
12%
Neuberger Berman Group LLC
7.8%
WELLINGTON MANAGEMENT GROUP LLP
7.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
14%
|
$557,830,300
6,523,568 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
13%
|
$516,481,857
6,040,017 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
12%
|
$462,293,483
5,406,309 shares
|
— | 31 Dec 2023 |
| Neuberger Berman Group LLC |
13F
Company
|
7.8%
|
$301,991,184
3,531,181 shares
|
— | 31 Dec 2023 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
7.2%
|
$279,453,776
3,268,083 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
3.9%
|
$153,031,774
1,789,636 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
296
Shares
51,176,074
Rows available
296
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
296
Q1 2024 holders
296
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|